Mandate

Fabege acquires Tornet property

July 20, 2006

Fabege AB has signed an agreement to acquire the remaining shares in the Fastighets AB Tornet. Fabege has owned 82.4% of the shares in Tornet for a while and this sale concerns the remaining 16.7 percent. The cash option of 146 Swedish Kronor per share involves an offer valued at approximately SEK 665 million.

Vinge acted as advisor to Fabege AB in the acquisition. Representatives from Vinge included Jan Lomback, Patrick Forslund and Mattias Friberg.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026